Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function

Glucagon-like peptide 1 (GLP-1) is a hormone secreted predominantly by the distal small intestine and colon and released in response to enteral nutrient exposure. GLP-1-based therapies are now used widely in the management of type 2 diabetes and have the potential to be effective antiobesity agents....

Descripción completa

Detalles Bibliográficos
Autores principales: Marathe, Chinmay S., Rayner, Christopher K., Jones, Karen L., Horowitz, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124003/
https://www.ncbi.nlm.nih.gov/pubmed/21747825
http://dx.doi.org/10.1155/2011/279530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124003/
https://www.ncbi.nlm.nih.gov/pubmed/21747825
http://dx.doi.org/10.1155/2011/279530

Ejemplares similares